Karen G. Anthony
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$3.1MFederal grants as PI9 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
9 awards · $3.1M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 19, 2025 | NIH | STTR Phase I Delivery of a candidate AgTRIOVx malaria vaccine by thermostable microneedle patches | $300K | L2 DIAGNOSTICS LLC |
| May 28, 2024 | NIH | STTR Phase I Delivery of a candidate AgTRIOVx malaria vaccine by thermostable microneedle patches | $300K | L2 DIAGNOSTICS LLC |
| Jun 10, 2020 | NIH | SBIR Phase I Development of A Narrow Spectrum Anti-Tubercular Agent | $286K | L2 DIAGNOSTICS LLC |
| Jun 24, 2019 | NIH | SBIR Phase I Development of A Narrow Spectrum Anti-Tubercular Agent | $300K | L2 DIAGNOSTICS LLC |
| Dec 21, 2018 | NIH | SBIR Phase I Therapeutic Inhibition of MIF to Improve Glucocorticoid Response | $154K | L2 DIAGNOSTICS LLC |
| Feb 8, 2018 | NIH | SBIR Phase I Therapeutic Inhibition of MIF to Improve Glucocorticoid Response | $299K | L2 DIAGNOSTICS LLC |
| Aug 16, 2017 | NIH | SBIR Phase II Allosteric MIF Inhibitors for Rheumatoid Arthritis Therapy | $781K | L2 DIAGNOSTICS LLC |
| Feb 28, 2017 | NIH | SBIR Phase II Allosteric MIF Inhibitors for Rheumatoid Arthritis Therapy | $6K | L2 DIAGNOSTICS LLC |
| Sep 19, 2016 | NIH | SBIR Phase II Allosteric MIF Inhibitors for Rheumatoid Arthritis Therapy | $695K | L2 DIAGNOSTICS LLC |
Peer ranks
Federal funding#622
Awards as PI#166
Patents#505
Companies
- L2 DIAGNOSTICS LLCLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.